Reliance Global Group, through its biotech division LifeSci Global, invested approximately $2 million in Innervate Radiopharmaceuticals, a company developing advanced PET imaging agents for neuroblastoma, a serious pediatric cancer. This investment marks Reliance's entry into the late-stage radiopharmaceutical sector, targeting a $250 million initial market with potential expansion into cardiovascular and neurodegenerative diseases, each possibly exceeding $1 billion. Innervate's lead product, 18F-mFBG, aims to improve cancer imaging with higher resolution and faster scans compared to current standards. The investment aligns with Reliance's strategy to build exposure in high-growth healthcare platforms and could offer significant near-term and long-term value, including potential regulatory incentives like a Priority Review Voucher.
On June 15, 2026, BlackRock, Inc. and its funds reduced their total holdings in Orion Corporation to below 5% of the company's shares and voting rights. This change was disclosed under the Finnish Securities Market Act, indicating a decrease from a p...
Autonomize, a healthcare AI platform, has strengthened its leadership by appointing three industry veterans to its Advisory Board and hiring Mike Longacre as Head of Transformation. These moves aim to help healthcare organizations move beyond AI pilo...
Fairfax Financial Holdings has finalized its acquisition of Kennedy-Wilson Holdings at $10.90 per share in cash, led by a consortium including Kennedy Wilson's CEO William McMorrow and affiliates of Fairfax. The Kennedy Wilson management team retains...
Aya Gold & Silver Inc., a Canadian precious metals mining company operating in Morocco, will be added to the VanEck Gold Miners ETF (GDX) effective June 19, 2026. This inclusion marks a significant milestone reflecting the company's growth in product...
Nephros, Inc. emphasizes its ultrafiltration technology's ability to capture microplastics and nanoplastics in water, following the U.S. EPA's April 2026 decision to list microplastics as a priority contaminant under the Safe Drinking Water Act. The ...
